Clinical trial
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate…
NCT00413660 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00413660 |
|---|---|
| Title | Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis |
| Official title | A Phase 2B, Randomized, Double Blind, Placebo-Controlled, Multicenter Study To Compare 6 Dose Regimens Of CP-690,550 Vs. Placebo, Each Combined With Methotrexate, Administered For 6 Months In The Treatment Of Subjects With Active Rheumatoid Arthritis Who Have Had An Inadequate Response To… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug, Other |
| Interventions | CP-690, 550, placebo |
| Enrollment | 509 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Dec 20, 2006 |
| Last update posted | Jan 18, 2013 |
| Countries | Argentina, Brazil, Bulgaria, Chile, Czechia, Hungary, Mexico, Poland, Slovakia, Spain, Sweden, Turkey (Türkiye) and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: